Suchergebnisse - "Rejeski, Kai"

PubPharm (4)

1

Applying the EHA/EBMT grading for ICAHT after CAR-T : comparative incidence and association with infections and mortality

enthalten in: Blood advances | 2024

von Rejeski, K. | Wang, Y. | Hansen, D. | +14

2

The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL

enthalten in: American journal of hematology | 2023

von Rejeski, K. | Wang, Y. | Albanyan, O. | +17

3

Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy

enthalten in: Cancer immunology research | 2023

von Rejeski, K. | Cordas Dos Santos, D. | Parker, N. | +14

CommentIn: Cancer Immunol Res. 2023 Jun 2;11(6):704. - PMID 37264818

4

CAR-HEMATOTOX : a model for CAR T-cell-related hematologic toxicity in relapsed/refractory large B-cell lymphoma

enthalten in: Blood | 2021

von Rejeski, K. | Perez, A. | Sesques, P. | +24

CommentIn: Blood. 2021 Dec 16;138(24):2447-2448. - PMID 34914831

1
[1]